Skip to main content
SpringerLink
Log in

Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A)

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

A therapeutic trial using repeated doses of a mouse monoclonal antibody against the tumor-associated antigen (TAA) CO17-1A in metastatic colorectal carcinomas was carried out. Metastatic lesions sampled by repeated thick needle (1.2 mm) biopsies during therapy were examined immunohistochemically for the presence of various TAAs, mouse IgG, complement, and infiltrating leukocytes. The CO17-1A was consistently expressed in all cases along the basement membrane of tumor glands and could only be demonstrated on cryostat sections whereas the TAAs GICA19-9, GA73-3, and Br55-2 were also visualized in B5-fixed paraffin-embedded biopsies. The CO17-1A and GA73-3 were predominantly present at the basal region in contrast to the GICA 19-9 and Br55-2 which were predominant at the luminal and the apical region of the tumor glands. Antigenic modulation was not seen either after 24–72 h or during prolonged treatment. In all cases the infused mouse IgG was detected, from 24 h after infusion up to 6–8 weeks, mainly along the basal region of tumor glands. In 13/14 posttreatment biopsies, complement factor C3 was found at the same sites as mouse IgG. In 6 out of 9 posttreatment biopsies an increase in mononuclear cells (monocytes, natural killer (NK) cells and/or T cells) was observed. Monocytes were close to the tumor cells whereas NK cells and T cells were predominantly scattered in the stroma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adams DO, Hall T, Steplewski Z, Koprowski H (1984) Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Proc Natl Acad Sci 81:3506

    Google Scholar 

  2. Bedikian AY, Chen TT, Malahy MA, Patt YZ, Bodey GP (1984) Prognostic factors influencing survival of patients with advanced colorectal cancer: Hepatic artery infusion versus systemic intravenous chemotherapy for liver metastases. J Clin Oncol 2:174

    Google Scholar 

  3. Bergmark S, Hagfström LO (1969) The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198

    Google Scholar 

  4. Dawson PM, Habib NA, Peck M, Blaxland JW, Luck RJ (1986) Patient survival with liver metastases from colorectal cancer — a district hospital experience. Eur J Surg Oncol 12:131

    Google Scholar 

  5. Douillard JY, Lehur PA, Vignoud J, Blottiere H, Maurel C, Thedrez P, Kremer M, Le Mevel B (1986) Monoclonal antibodies specific immunotherapy of gastro-intestinal tumors. Hybridoma 5 (suppl I):139

    Google Scholar 

  6. Dukes CE, Bussey HJR (1958) The spread of rectal cancer and its effects on prognosis. Br J Cancer 12:309

    Google Scholar 

  7. Ekberg H, Tranberg KG, Lundstedt C, Hahff G, Ranstam J, Jeppsson B, Bengmark S (1986) Determinants of survival after intraarterial infusion of 5-fluorouracil for liver metastases from colorectal cancer: A multivariate analysis. J Surg Oncol 31:246

    Google Scholar 

  8. Frödin JE, Biberfeld P, Christensson B, Philstedt P, Sundelius S, Sylvén M, Wahren B, Koprowski H, Mellstedt H (1986) Treatment of patients with metastasizing colo-rectal carcinoma with mouse monoclonal antibodies (MOAb17–1A). A progress report. Hybridoma 5 (suppl I):151

    Google Scholar 

  9. Garcia CF, Lowder J, Meeker TC, Bindl J, Levy R, Warnke RA (1985) Differences in “host infiltrates” among lymphoma patients treated with anti-idiotype antibodies: correlation with treatment response. J Immunol 135:4252

    Google Scholar 

  10. Goslin R, Steele Jr G, Zamcheck N, Mayer R, MacIntyre J (1982) Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25:749

    CAS  PubMed  Google Scholar 

  11. Herlyn DM, Koprowski H (1982) IgG2A monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci 79:4761

    Google Scholar 

  12. Herlyn DM, Herlyn MF, Steplewski Z, Koprowski H (1979) Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colo-rectal carcinoma. Eur J Immunol 9:657

    Google Scholar 

  13. Herlyn DM, Herlyn MF, Ross AH, Ernst C, Atkinson B, Koprowski H (1984) Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J Immunol Methods 73:157

    Google Scholar 

  14. Herlyn MF, Steplewski Z, Herlyn DM, Koprowski H (1986) CO17–1A and related monoclonal antibodies: Their production and characterization. Hybridoma 5 (suppl I):3

    Google Scholar 

  15. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase Complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29:577

    CAS  PubMed  Google Scholar 

  16. Magnani JL, Nilson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, Ginsburg V (1982) A monoclonal antibody defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 257:14365

    Google Scholar 

  17. Mason DY, Bell JJ, Christensson B, Biberfeld P (1980) An immunohistological study of human lymphoma. Clin Exp Immunol 40:235

    Google Scholar 

  18. Mellstedt H, Frödin J-E, Christensson B, Shetye J, Biberfeld P, Lefvert A-K, Pihlstedt P, Sylvén M, Makower J, Wahren B, Ahlman B, Cedermark B, Erwald R, Klingenström P, Nathansson J, Rieger A, Koprowski H (1988) Application of monoclonal antibodies (MAb 17–1A) in the treatment of colorectal carcinomas: In: Carrano RA, Douillard JY (eds) Monoclonal antibodies in clinical oncology. Marcel Dekker, New York (in press)

    Google Scholar 

  19. Mellstedt H, Frödin J-E, Masucci G, Lindemalm C, Wedelin C, Christensson B, Shetye J, Biberfeld P, Lefvert A-K, Pihlstedt P, Makower J, Harmenberg U, Wahren B, Ahlman B, Cedermark B, Erwald R, Magnusson I, Nathansson J, Rieger A (1988) MAb 17–1A used for therapy of patients with metastatic colorectal carcinomas. In: Beger HG, Reisfeld R (eds) New approaches in cancer treatment. Springer-Verlag, Berlin (in press)

    Google Scholar 

  20. Neville AM, Gusterson BA (1985) Monoclonal antibodies and human tumors; pathological and clinical aspects. Eur J Cancer Clin Oncol 21:355

    Google Scholar 

  21. Porwit-Ksiazek A, Ksiazek T, Biberfeld P (1983) Leu-7+ (HNK-1+) cells. I. Selective compartmentalisation of Leu-7+ cells with different immunophenotypes in lymphatic tissues and blood. Scand J Immunol 18:485

    Google Scholar 

  22. Ross AH, Herlyn D, Diopoulos D, Koprowski H (1986) Isolation and characterization of a carcinoma-associated antigen. Biochem Biophys Res Commun 135:297

    Google Scholar 

  23. Schulz G, Staffileno LK, Reisfeld RA, Dennert G (1985) Eradication of established human melanoma tumor in nude mice by antibody-directed effector cells. J Exp Med 161:1315

    Google Scholar 

  24. Sears HF, Mattis J, Herlyn DM, Häyry P, Atkinson B, Ernst C, Steplewski Z, Koprowski H (1982) Phase I clinical trial of monoclonal antibody in treatment of gastro-intestinal tumors. Lancet I:762

    Google Scholar 

  25. Sears HF, Herlyn DM, Häyry P, Atkinson B, Ernst C, Steplewski Z, Koprowski H (1985) Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastro-intestinal adenocarcinoma. Cancer Res 45:5910

    Google Scholar 

  26. Sears HF, Herlyn DM, Steplewski Z, Koprowski H (1986) Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastro-intestinal adenocarcinoma. Hybridoma 5 (suppl I):109

    Google Scholar 

  27. Shen JW, Atkinson B, Koprowski H, Sears HF (1984) Binding of murine immunoglobulin to human tissues after immunotherapy with anti-colo-rectal carcinoma monoclonal antibody. Int J Cancer 33:465

    Google Scholar 

  28. Sindelar WF, Maher MM, Herlyn D, Sears HF, Steplewski Z, Koprowski H (1986) Trial of therapy with monoclonal antibody 17–1A in pancreatic carcinoma. Preliminary results. Hybridoma 5 (suppl I):125

    Google Scholar 

  29. Steplewski Z, Herlyn D, Lubeck M, Kimoto Y, Herlyn M, Koprowski H (1986) Mechanisms of tumor growth inhibition. Hybridoma 5 (suppl I):59

    Google Scholar 

  30. Tempero MA, Pour PM, Uchida E, Herlyn D, Steplewski Z (1986) Monoclonal antibody CO17–1A and leukapheresis in immunotherapy of pancreatic cancer. Hybridoma 5 (suppl I):133

    Google Scholar 

  31. Blaszczyk-Thurin M, Thurin J, Hindsgaul O, Karlsson KA, Steplewski Z, Koprowski H (1987) Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody: Isolation and characterization by mass spectrometry and NMR spectroscopy. J Biol Chem 262(1):372

    Google Scholar 

  32. Verrill H, Goldberg M, Rosenbaum R, Abbott R, Simunovic L, Steplewski Z, Koprowski H (1986) Clinical trial of Wistar Institute 17–1A monoclonal antibody in patients with advanced gastro-intestinal adenocarcinoma. A preliminary report. Hybridoma 5 (suppl I):175

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Karolinska Institute and Hospital, Stockholm, Sweden

    Jayant Shetye, Birger Christensson, Crawford Grant, Björn Jacobsson & Peter Biberfeld

  2. Department of Oncology and Immunology Research Laboratory, Radiumhemmet, Karolinska Institute and Hospital, Stockholm, Sweden

    Jayant Shetye, Jan-Erik Frödin & H»kan Mellstedt

  3. Department of Diagnostic Radiology, Karolinska Institute and Hospital, Stockholm, Sweden

    Staffan Sundelius & Mikael Sylvén

Authors
  1. Jayant Shetye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan-Erik Frödin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Birger Christensson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Crawford Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Björn Jacobsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Staffan Sundelius
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mikael Sylvén
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Peter Biberfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H»kan Mellstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported by grants from the Cancer Society in Stockholm, the King Gustav Vth Jubilee Fund, The Swedish Cancer Society and the Karolinska Institute Foundations

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shetye, J., Frödin, JE., Christensson, B. et al. Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A). Cancer Immunol Immunother 27, 154–162 (1988). https://doi.org/10.1007/BF00200021

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00200021

Keywords

Search

Navigation